As betaine has shown to ameliorate conditions in AD by acting against the oxidative stress induced by generation and deposition of amyloid-β and toxic homocysteine, this kind of upregulation of BGT-1 could be a response to the increased oxidative and osmotic stress during AD [71–73]. This evidence concerns the gene SLC6A12 and Alzheimer disease.